Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,334
datasets available to search
ShareScore release 0.9.0
Dataset results
1,334 results for “Hematology”
First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies
ClinicalTrials.gov study NCT05348889. IPD Sharing: NO. Countries: 1. Publications: 0.
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripher
ClinicalTrials.gov study NCT06859424. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors
ClinicalTrials.gov study NCT02071888. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer
ClinicalTrials.gov study NCT00255710. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat
ClinicalTrials.gov study NCT04712942. IPD Sharing: NO. Countries: 1. Publications: 0.
Stem Cell Transplantation for Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT00152139. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
ClinicalTrials.gov study NCT00897260. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Cell Therapy for Adults With Hematologic Malignancies
ClinicalTrials.gov study NCT00208962. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
ClinicalTrials.gov study NCT00223483. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
ClinicalTrials.gov study NCT07147621. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Diet and Cognitive Training in Hematologic Cancer Survivors
ClinicalTrials.gov study NCT05708716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies
ClinicalTrials.gov study NCT07189117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies
ClinicalTrials.gov study NCT02017613. IPD Sharing: NO. Countries: 2. Publications: 0.
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
ClinicalTrials.gov study NCT06914037. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
ClinicalTrials.gov study NCT06034275. IPD Sharing: NO. Countries: 1. Publications: 0.
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
ClinicalTrials.gov study NCT03588936. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
ClinicalTrials.gov study NCT04603001. IPD Sharing: NO. Countries: 12. Publications: 0.
A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors
ClinicalTrials.gov study NCT04214093. IPD Sharing: YES. Countries: 1. Publications: 0.
Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant
ClinicalTrials.gov study NCT00476177. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy In
ClinicalTrials.gov study NCT01280240. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.